The electronic nose: emerging biomarkers in lung cancer diagnostics
Lung cancer is very common and the most common cause of cancer death worldwide. Despite recent progress in the systemic treatment of lung cancer (checkpoint inhibitors and tyrosine kinase inhibitors), each year, >1.5 million people die due to this disease. Most lung cancer patients already have a...
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Respiratory Society
2019-12-01
|
| Series: | Breathe |
| Online Access: | http://breathe.ersjournals.com/content/15/4/e135.full |